Visceral Pain Treatment Market Analysis By Drug Type (Pain modifiers (Tricyclic Anticonvulsant and Tricyclic Antidepressants), Analgesics (Narcotics and NSAID), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Channels) & Forecast 2024-2035
- PUBLISHED ON
- 24/03/2023
- NO OF PAGES
- 268
- CATEGORY
- Healthcare & Life Sciences
The visceral pain treatment market refers to the pharmaceuticals, medical devices, and therapies used to alleviate pain originating from organs within the body's cavities, such as the gastrointestinal tract, urinary tract, and reproductive organs. This type of pain can be caused by inflammation, infection, injury, or other conditions affecting the internal organs.
The market for visceral pain treatment is expected to grow in the coming years due to an increasing prevalence of conditions such as inflammatory bowel disease, chronic pelvic pain, and urinary tract infections. Additionally, the aging population is also expected to drive demand for visceral pain treatments as older adults are more prone to develop chronic pain conditions.
There are several categories of medications used to treat visceral pain, including analgesics, anti-inflammatory drugs, and antidepressants. Medical devices such as neurostimulation devices and implantable drug delivery systems are also being developed to treat visceral pain.
The major players in the visceral pain treatment market include pharmaceutical companies such as Pfizer, Inc., AstraZeneca, and GlaxoSmithKline plc, as well as medical device manufacturers such as Medtronic plc and Boston Scientific Corporation.
Overall, the visceral pain treatment market is expected to continue to grow as new treatments are developed and as demand increases due to the aging population and increasing prevalence of chronic pain conditions.
Segment Overview
The visceral pain treatment market can be segmented based on several factors, including the type of treatment, the application, and the region.
Based on the type of treatment, the market can be segmented into:
• Analgesics - This includes opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and acetaminophen, which are commonly used to relieve pain.
• Antidepressants - Certain antidepressants, such as tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors (SNRIs), are used to treat chronic pain.
• Anti-inflammatory drugs - These drugs, such as corticosteroids, are used to reduce inflammation and relieve pain associated with conditions such as inflammatory bowel disease.
• Medical devices - This includes neurostimulation devices and implantable drug delivery systems that can deliver pain medication directly to the affected area.
Based on the application, the market can be segmented into:
• Gastrointestinal disorders - This includes conditions such as inflammatory bowel disease, gastroesophageal reflux disease, and peptic ulcers.
• Urological disorders - This includes conditions such as urinary tract infections, interstitial cystitis, and bladder pain syndrome.
• Gynecological disorders - This includes conditions such as endometriosis, dysmenorrhea, and chronic pelvic pain.
Based on the region, the market can be segmented into:
• North America - This includes the United States and Canada.
• Europe - This includes countries such as the United Kingdom, Germany, France, Italy, and Spain.
• Asia Pacific - This includes countries such as China, India, Japan, and Australia.
• Rest of the World - This includes regions such as Latin America, the Middle East, and Africa.
Geographical Overview
The visceral pain treatment market can be analyzed based on geography, and it is segmented into various regions, including:
• North America: The United States and Canada are the major markets for visceral pain treatment in North America. The region has a high prevalence of chronic pain conditions, and a large population suffering from gastrointestinal, urological, and gynecological disorders.
• Europe: The United Kingdom, Germany, France, Italy, and Spain are the major markets for visceral pain treatment in Europe. The region has a well-established healthcare infrastructure and a high prevalence of chronic pain conditions, which drives demand for visceral pain treatments.
• Asia Pacific: China, Japan, India, and Australia are the major markets for visceral pain treatment in the Asia Pacific region. The region has a large population suffering from chronic pain conditions and is witnessing a rise in healthcare expenditure, which is expected to boost the market growth.
• Latin America: Brazil, Mexico, and Argentina are the major markets for visceral pain treatment in Latin America. The region has a high prevalence of chronic pain conditions, and the increasing healthcare spending is expected to drive the market growth.
• Middle East and Africa: Saudi Arabia, South Africa, and the United Arab Emirates are the major markets for visceral pain treatment in the Middle East and Africa. The region has a growing demand for visceral pain treatments due to the increasing prevalence of chronic pain conditions and a rise in healthcare expenditure.
Overall, the global visceral pain treatment market is expected to witness significant growth in the coming years, driven by increasing demand for pain management solutions and rising prevalence of chronic pain conditions across the world.
COVID Impact
The COVID-19 pandemic has had a significant impact on the visceral pain treatment market. While the pandemic has resulted in a surge in demand for healthcare services, including pain management, it has also disrupted supply chains and manufacturing operations, leading to a shortage of drugs and medical devices.
Additionally, the pandemic has also resulted in the diversion of healthcare resources towards managing COVID-19 patients, leading to delays in non-urgent medical procedures and consultations for chronic pain management.
The lockdowns and social distancing measures implemented in many countries have also affected patient access to healthcare facilities, resulting in reduced patient visits and delayed treatment. This has particularly affected patients suffering from chronic pain conditions, who require regular medical consultations and treatments.
On the positive side, the pandemic has also accelerated the adoption of telemedicine and remote consultations for chronic pain management, enabling patients to receive medical care from the safety of their homes.
In terms of market trends, the pandemic has highlighted the importance of drug diversification and local production to ensure uninterrupted supply chains. Additionally, the pandemic has also underscored the need for a more patient-centric approach to healthcare, with greater focus on personalized treatments and improved patient outcomes.
Overall, while the COVID-19 pandemic has had a significant impact on the visceral pain treatment market, the market is expected to recover and grow in the coming years as the pandemic subsides and healthcare systems adapt to the new normal.
Competitive Analysis
The visceral pain treatment market is highly competitive, with several players operating in the market.
1. Pfizer Inc.
2. AstraZeneca plc.
3. Eli Lilly and Company
4. GlaxoSmithKline plc.
5. Abbott Laboratories
6. Merck & Co. Inc.
7. Novartis AG
8. Johnson & Johnson
9. Sanofi S.A.
10. Teva Pharmaceutical Industries Ltd.
These companies are focusing on research and development activities to develop new drugs and medical devices for visceral pain management. They are also adopting strategies such as mergers and acquisitions, partnerships, and collaborations to expand their market presence and enhance their product portfolios.
In addition to these established players, there are several emerging players in the market that are focusing on developing innovative solutions for visceral pain management. These companies are leveraging advanced technologies such as artificial intelligence and machine learning to develop personalized pain management solutions for patients.
Overall, the competitive landscape of the visceral pain treatment market is expected to remain intense, with players focusing on innovation, product differentiation, and strategic collaborations to gain a competitive edge in the market. The market is expected to witness significant growth in the coming years, driven by increasing demand for pain management solutions and rising prevalence of chronic pain conditions across the world.
Historic Year: 2016-2022
Forecast: 2024-2035
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI